Pricing Log in Create free account

Apnimed, Inc. (APMD) vs Geron Corporation (GERN)

Apnimed, Inc. and Geron Corporation are both Biotechnology companies. Apnimed, Inc. and Geron Corporation are of similar size ($637.7M and $628.6M). Geron Corporation has negative trailing earnings, so its P/E is not meaningful; Apnimed, Inc. trades at 0.8×. Apnimed, Inc. has the higher net margin (81.6% vs −22.0%) and the higher return on invested capital (0.00% vs −34.1%). Across the 15 metrics below, Apnimed, Inc. leads on 11 and Geron Corporation on 4.

Valuation

Metric APMD GERN Biotechnology median
P/E 0.77 n/m 10.60
P/S 0.62 3.06 9.40
P/B n/m 2.94 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales (0.18) 2.62 9.02
Earnings yield 130.69% (7.41%) (32.88%)
Free cash flow yield (115.62%) (13.70%) (23.13%)

Profitability

Metric APMD GERN Biotechnology median
Gross margin 94.53% 91.59% 68.51%
Operating margin 19.88% (14.75%) 0.00%
Net margin 81.56% (21.99%) 0.00%
Free cash flow margin (71.50%) (41.91%) 0.00%
Return on equity 0.00% (20.12%) (51.96%)
Return on assets 0.00% (8.74%) (46.06%)
Return on invested capital 0.00% (34.12%) 0.00%

Growth

Metric APMD GERN Biotechnology median
Revenue growth (TTM) — 18.60% 6.76%
EPS growth (last fiscal year) (14.69%) 51.85% 29.88%
Revenue growth, 5-year CAGR — 273.49% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric APMD GERN Biotechnology median
Debt to equity (0.45) 0.53 0.00
Current ratio 5.19 6.31 4.97
Net debt to EBITDA 0.02 3.28 1.01

Dividend

Metric APMD GERN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APMD GERN Biotechnology median
Market cap 628.62m 637.67m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack